Results
|
|
941.
|
Lapatinib with ECF/X in the first-line treatment of metastatic gastric cancer according to HER2neu and EGFR status: a randomized placebo-controlled phase II study (EORTC 40071). [electronic resource] by
- Moehler, Markus
- Schad, Arno
- Maderer, Annett
- Atasoy, Ajlan
- Mauer, Murielle E
- Caballero, Carmela
- Thomaidis, Thomas
- John, Jestinah M Mahachie
- Lang, Istvan
- Van Cutsem, Eric
- Freire, João
- Lutz, Manfred P
- Roth, Arnaud
Producer: 20190729
In:
Cancer chemotherapy and pharmacology vol. 82
Availability: No items available.
|
|
|
942.
|
HER-targeted tyrosine kinase inhibitors enhance response to trastuzumab and pertuzumab in HER2-positive breast cancer. [electronic resource] by
- Canonici, Alexandra
- Ivers, Laura
- Conlon, Neil T
- Pedersen, Kasper
- Gaynor, Nicola
- Browne, Brigid C
- O'Brien, Neil A
- Gullo, Giuseppe
- Collins, Denis M
- O'Donovan, Norma
- Crown, John
Producer: 20200220
In:
Investigational new drugs vol. 37
Availability: No items available.
|
|
|
943.
|
|
|
|
944.
|
|
|
|
945.
|
|
|
|
946.
|
Antitumor efficacy of IPI-504, a selective heat shock protein 90 inhibitor against human epidermal growth factor receptor 2-positive human xenograft models as a single agent and in combination with trastuzumab or lapatinib. [electronic resource] by
- Leow, Ching Ching
- Chesebrough, Jon
- Coffman, Karen T
- Fazenbaker, Christine A
- Gooya, John
- Weng, David
- Coats, Steve
- Jackson, Dowdy
- Jallal, Bahija
- Chang, Yong
Producer: 20100119
In:
Molecular cancer therapeutics vol. 8
Availability: No items available.
|
|
|
947.
|
|
|
|
948.
|
|
|
|
949.
|
|
|
|
950.
|
|
|
|
951.
|
Dynamic transcription factor activity and networks during ErbB2 breast oncogenesis and targeted therapy. [electronic resource] by
- Weiss, M S
- Peñalver Bernabé, B
- Shin, S
- Asztalos, S
- Dubbury, S J
- Mui, M D
- Bellis, A D
- Bluver, D
- Tonetti, D A
- Saez-Rodriguez, J
- Broadbelt, L J
- Jeruss, J S
- Shea, L D
Producer: 20150709
In:
Integrative biology : quantitative biosciences from nano to macro vol. 6
Availability: No items available.
|
|
|
952.
|
|
|
|
953.
|
EGFR and HER2 signals play a salvage role in MEK1-mutated gastric cancer after MEK inhibition. [electronic resource] by
- Mizukami, Takuro
- Togashi, Yosuke
- Sogabe, Shunsuke
- Banno, Eri
- Terashima, Masato
- De Velasco, Marco A
- Sakai, Kazuko
- Fujita, Yoshihiko
- Tomida, Shuta
- Nakajima, Takako Eguchi
- Boku, Narikazu
- Nishio, Kazuto
Producer: 20160524
In:
International journal of oncology vol. 47
Availability: No items available.
|
|
|
954.
|
Assessment of a HER2 scoring system for colorectal cancer: results from a validation study. [electronic resource] by
- Valtorta, Emanuele
- Martino, Cosimo
- Sartore-Bianchi, Andrea
- Penaullt-Llorca, Frédérique
- Viale, Giuseppe
- Risio, Mauro
- Rugge, Massimo
- Grigioni, Walter
- Bencardino, Katia
- Lonardi, Sara
- Zagonel, Vittorina
- Leone, Francesco
- Noe, Johannes
- Ciardiello, Fortunato
- Pinto, Carmine
- Labianca, Roberto
- Mosconi, Stefania
- Graiff, Claudio
- Aprile, Giuseppe
- Frau, Barbara
- Garufi, Carlo
- Loupakis, Fotios
- Racca, Patrizia
- Tonini, Giuseppe
- Lauricella, Calogero
- Veronese, Silvio
- Truini, Mauro
- Siena, Salvatore
- Marsoni, Silvia
- Gambacorta, Marcello
Producer: 20160825
In:
Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc vol. 28
Availability: No items available.
|
|
|
955.
|
A phase I pharmacokinetics study of lapatinib and tamoxifen in metastatic breast cancer (EORTC 10053 Lapatam study). [electronic resource] by
- Fumoleau, Pierre
- Koch, Kevin M
- Brain, Etienne
- Lokiec, François
- Rezai, Keyvan
- Awada, Ahmad
- Hayward, Larry
- Werutsky, Gustavo
- Bogaerts, Jan
- Marréaud, Sandrine
- Cardoso, Fatima
Producer: 20150622
In:
Breast (Edinburgh, Scotland) vol. 23
Availability: No items available.
|
|
|
956.
|
|
|
|
957.
|
|
|
|
958.
|
|
|
|
959.
|
A randomized phase II study to determine the efficacy and tolerability of two doses of eribulin plus lapatinib in trastuzumab-pretreated patients with HER-2-positive metastatic breast cancer (E-VITA). [electronic resource] by
- Bischoff, Joachim
- Barinoff, Jana
- Mundhenke, Christoph
- Bauerschlag, Dirk O
- Costa, Serban-Dan
- Herr, Daniel
- Lübbe, Kristina
- Marmé, Frederik
- Maass, Nicolai
- von Minckwitz, Gunter
- Grischke, Eva-Maria
- Müller, Volkmar
- Schmidt, Marcus
- Gerber, Bernd
- Kümmel, Sherko
- Schumacher, Claudia
- Krabisch, Petra
- Seiler, Sabine
- Thill, Marc
- Nekljudova, Valentina
- Loibl, Sibylle
Producer: 20200909
In:
Anti-cancer drugs vol. 30
Availability: No items available.
|
|
|
960.
|
Study of the biologic effects of lapatinib, a reversible inhibitor of ErbB1 and ErbB2 tyrosine kinases, on tumor growth and survival pathways in patients with advanced malignancies. [electronic resource] by
- Spector, Neil L
- Xia, Wenle
- Burris, Howard
- Hurwitz, Herbert
- Dees, E Claire
- Dowlati, Afshin
- O'Neil, Bert
- Overmoyer, Beth
- Marcom, Paul K
- Blackwell, Kimberly L
- Smith, Deborah A
- Koch, Kevin M
- Stead, Andrew
- Mangum, Steven
- Ellis, Matthew J
- Liu, Leihua
- Man, Albert K
- Bremer, Troy M
- Harris, Jennifer
- Bacus, Sarah
Producer: 20050505
In:
Journal of clinical oncology : official journal of the American Society of Clinical Oncology vol. 23
Availability: No items available.
|